Cornerstone Therapeutics Receives CARDENE(R) I.V.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cornerstone Therapeutics Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter

CARY, NC--(Marketwired - Jun 13, 2013) - Cornerstone Therapeutics Inc. ( NASDAQ : CRTX ) ("Cornerstone" or the "Company") today announced that on June 11, 2013 the Company received a Paragraph IV Notice Letter from Exela Pharma Sciences, LLC ("Exela") advising the Company of the filing by Exela of a supplemental New Drug Application seeking approval for a ready to use injectable formulation of 0.1 mg/mL and 0.2 mg/mL nicardipine hydrochloride in 0.9% sodium chloride. The Company markets a ready to use injectable formulation of 0.1 mg/mL and 0.2 mg/mL nicardipine hydrochloride in 0.86% and 0.83% sodium chloride, respectively, under the name CARDENE ® I.V. (nicardipine hydrochloride) Premixed Injection.

Cornerstone is currently reviewing the details of this Notice Letter and will pursue all available legal and regulatory avenues in defense of CARDENE® I.V. (nicardipine hydrochloride) Premixed Injection, including enforcement of their intellectual property rights and approved labeling.

About Cornerstone Therapeutics

Cornerstone Therapeutics Inc. ( NASDAQ : CRTX ), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Key elements of the Company's strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek out opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within the Company's focus areas; and generate revenues by marketing approved generic products through the Company's wholly-owned subsidiary, Aristos Pharmaceuticals, Inc. For more information, visit www.crtx.com .

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein, other than statements of historical fact, including our strategy and our future operations and opportunities, constitute forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including our ability to satisfy FDA and other regulatory requirements, our ability to develop and maintain the necessary sales, marketing, supply chain and distribution capabilities to successfully commercialize our products, our ability to obtain, maintain and enforce patent and other intellectual property protection for our products and product candidates and the other factors described in Item 1A (Risk Factors) of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the SEC) on March 14, 2013 and in our subsequent filings with the SEC. In addition, the statements in this press release reflect our expectations and beliefs only as of the date of this release. We anticipate that subsequent events and developments may cause our expectations and beliefs to change. However, while we may elect to update these forward-looking statements publicly at some point in the future, we specifically disclaim any obligation to do so, whether as a result of new information, future events or otherwise, except as may be required by law. Our forward-looking statements do not reflect the potential impact of any acquisitions, mergers, dispositions, business development transactions, joint ventures or investments that we may make or enter into. These forward-looking statements should not be relied upon as representing our views as of any date after the date of this release.

Trademarks

CARDENE® I.V. is a registered trademark of EKR Therapeutics, Inc., Cornerstone Therapeutics' wholly-owned subsidiary.

Contacts Investor Relations Contact: Josh Franklin Vice President, Strategy and Business Development +1-919-678-6520 josh.franklin@crtx.com Media Relations Contact: Fleishman-Hillard Andrea Moody +1-919-457-0743 andrea.moody@fleishman.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 75

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 102

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 80

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 112

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 291

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 22

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
InPHRED's Award Brings 1310 nm VCSELs Into Focus at IEEE

Updated Category News Views 64

A stubborn mirror problem just put InPHRED on the photonics map. InPHRED, founded in 2023, took the Best Technology award at the inaugural 2026 IEEE Photonics Conference Start-Up Competition, selected from seven finalists. That is a meaningful industry pat on the back, particularly because the company is aiming at a real engineering headache rather than waving around...

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 11

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 71

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading

Top 5 Most Recently Viewed Articles

VICTOR Pet Food Launches New Line for Sensitive Dogs and Puppies

Updated Category News Views 313

VICTOR Pet Food Launches New Line for Sensitive Dogs and Puppies VICTOR Super Premium Pet Food, known for its dedication to high-quality pet nutrition, is proud to unveil a new line aimed specifically at canines with sensitive skin and stomach issues. The Sensitive Skin and Stomach line is designed to meet the dietary needs of both adult dogs and puppies, and will be...

Continue Reading
Exploring the Growth of the Pressure Monitoring Market

Updated Category News Views 181

The Expanding Pressure Monitoring Market This flourishing sector is gaining significant traction, reflecting a market valued at approximately US$13.63 billion in 2024, with a current rise to US$14.56 billion in 2025. The forecast indicates a notable compound annual growth rate (CAGR) of 8.3% from this point through 2032, culminating in an anticipated valuation of US$25.48...

Continue Reading
Citadel Credit Union Champions Community Engagement Initiatives

Updated Category News Views 636

Citadel Credit Union's Commitment to Community Support Citadel Credit Union is dedicated to reaffirming its commitment to its members and the surrounding region through an innovative approach to philanthropy. The organization has escalated its focus on community partnerships and employee-driven initiatives, making strides toward becoming a leader in promoting meaningful...

Continue Reading
TRIMEDX Bolsters Leadership with New Chief Data & AI Officer

Updated Category News Views 163

TRIMEDX Elevates Leadership with a Visionary Hire Indianapolis—TRIMEDX, a leading name in independent clinical asset management, is taking substantial strides in enhancing its technological offerings. The company has recently welcomed Srilekha Akula as its Chief Data & AI Officer. Her arrival marks a pivotal moment in TRIMEDX's journey, aimed at fostering innovation and...

Continue Reading
Exploring the Leadership of Ford as a Dividend Powerhouse

Updated Category News Views 170

Ford Motor Company (NYSE: F) has been a staple name in the automotive sector, but it’s got some serious hurdles to jump over. The stock price took a 12% nosedive over the past year, and while that might raise eyebrows, it also sets the stage for potential dividend plays. The price-to-earnings ratio is sitting pretty low at 11—sounds tempting for those looking at...

Continue Reading